- Nawah Scientific raises USD 23M Series A, combining equity and debt, to expand labs and build a global R&D center.
- Founded in 2015 by Omar Shoukry Sakr, Nawah has tested over one million samples and serves clients in 30+ countries.
- The company operates four units, Life Science, Food & Agriculture, Pharma, and CRM, offering advanced testing and certified reference materials.
Nawah Scientific
Egypt’s Nawah Scientific raised USD 23 million in a series A funding round in a mix of equity and debt. The round was led by Life Ventures Holding, with participation from Den Ventures, Empire M, AfricInvest, and Elsewedy. The round also saw participation from banks and angel investors.
Looking forward, with the funding, it aims to build a 10,000-sqm global R&D center in Rwanda. It also aims to double its lab capacity in Egypt and Saudi Arabia, and expand across North Africa and Europe.
LIfe Science
Founded in 2015 by Omar Shoukry Sakr, Nawah Scientific is a deep-tech and life science company. It specializes in scientific and industrial testing services. Its cloud lab model enables researchers and companies to run advanced testing remotely. Thus far, Nawah has tested over one million samples, employs 160 researchers, and serves clients in over thirty countries.
The company operates four business units:
- Life Science Research: its core platform for advanced testing and research services
- Food & Agriculture: certified safety and quality testing for producers and exporters
- Pharma: R&D and formulation support for pharmaceuticals and cosmetics
- CRM: Produces certified reference materials to supply the critical standards used for calibration, method validation, and quality control across labs and regulated industries.
If you see something out of place or would like to contribute to this story, check out our Ethics and Policy section.









